National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
Quick Links
Director's Corner
Updates from the Director

Dictionary of Cancer Terms
Cancer-related terms

NCI Drug Dictionary
Definitions, names, and links

Funding Opportunities
Research and training

NCI Publications
Order/download free booklets

Advisory Boards and Groups
Information, meetings, reports

Science Serving People
Learn more about NCI

Español
Información en español
Quit Smoking Today
NCI Highlights
Report to Nation Finds Declines in Cancer Incidence, Death Rates

High Dose Chemotherapy Prolongs Survival for Leukemia

Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E

The Nation's Investment in Cancer Research FY 2009

Past Highlights
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

lomustine
A nitrosourea with antineoplastic activity. Lomustine alkylates and crosslinks DNA, thereby inhibiting DNA and RNA synthesis. This agent also carbamoylates DNA and proteins, resulting in inhibition of DNA and RNA synthesis and disruption of RNA processing. Lomustine is lipophilic and crosses the blood-brain barrier. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Synonym:Lomustinum
US brand name:CeeNU
Foreign brand names:Belustin
Belustine
Cecenu
Citostal
Lomeblastin
Lucostin
Lucostine
Prava
Abbreviation:CCNU
Code names:RB-1509
WR-139017
Chemical structure names:
  • 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea
  • Chloroethylcyclo-hexylnitrosourea
  • N-(2-chloroethyl)-N'-cyclohexyl-N-nitrosourea



Previous:LMB-7 immunotoxin, LMB-9 immunotoxin, lobradimil, Lodine, lometrexol
Next:lonafarnib, lonaprisan, loperamide hydrochloride, lopinavir, lorazepam

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov